AF
CGEM icon

Allworth Financial’s Cullinan Oncology CGEM Stock Holding History

Allworth Financial’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.7K Buy
2,893
+1,747
+152% +$25.9K ﹤0.01% 2430
2026
Q1 		$16.3K Buy
1,146
+501
+78% +$6.44K ﹤0.01% 3142
2025
Q4 		$6.68K Buy
645
+89
+16% +$803 ﹤0.01% 3535
2025
Q3 		$3.3K Buy
556
+289
+108% +$2.12K ﹤0.01% 3777
2025
Q2 		$2.01K Buy
267
+26
+11% +$209 ﹤0.01% 3695
2025
Q1 		$1.96K Buy
+241
New +$2.31K ﹤0.01% 3225
2023
Q3 		– Sell
-31
Closed -$334 – 3453
2023
Q2 		$334 Buy
+31
New +$329 ﹤0.01% 2983
2022
Q3 		– Sell
-46
Closed -$1K – 2700
2022
Q2 		$1K Buy
+46
New +$522 ﹤0.01% 2111

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Allworth Financial's CGEM Position: Q2 2026 in Review

Allworth Financial increased its Cullinan Oncology (CGEM) stake by 152% in Q2 2026, buying an estimated $25.9K and bringing the position to 2,893 shares worth $52.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2430.

Allworth Financial first reported a position in CGEM in Q2 2022 and has held it in 8 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Allworth Financial held 2,893 shares of Cullinan Oncology worth $52.7K as of Q2 2026.
  • Allworth Financial bought 1,747 Cullinan Oncology shares in Q2 2026, an estimated $25.9K.
  • Cullinan Oncology made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2430 holding.
  • Allworth Financial first reported a position in Cullinan Oncology in Q2 2022 and has held it in 8 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.